Home » Shire to Move Forward With Baxalta Merger Despite Treasury Inversion Rules
Shire to Move Forward With Baxalta Merger Despite Treasury Inversion Rules
One day after Pfizer announced it was terminating its proposed merger with Ireland’s Allergan, a seemingly undeterred Shire said it still intends to pursue Baxalta.
The company said it expects to complete the merger by mid-2016, as originally planned.
Shire’s announcement came after the Obama administration unveiled regulations that would restrict firms from acquiring smaller foreign companies as a way to change their tax residence and avoid paying U.S. taxes.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May